Mesenchymal stromal cells derived from umbilical cord blood migrate in response to complement C1q

References

• Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9:11–15.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hirai M, Cantero S, Ciubotariu R, Dobrila L, Hirsh A, . Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cell Biochem. 2011;112:1206–18.
   PubMed Web of Science ®Google Scholar
• Hass R, Kasper C, Böhm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011;14;9–12.
   Google Scholar
• El-Badri NW, Hakki A, Saporta S, Liang X, Madhusondanan S, Willing AE, . Cord blood mesenchymal stem cells: potential use in neurological disorders. Stem Cells Dev. 2006;15:497–506.
   PubMedGoogle Scholar
• Nishiyama N, Miyoshi S, Hida N, Uyama T, Okamoto K, Ikegami Y, . The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells. 2007;25:2017–24.
   PubMed Web of Science ®Google Scholar
• Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells. 2010; 28:585–96.
   PubMed Web of Science ®Google Scholar
• Fox JM, Chamberlain G, Ashton BA, Middleton J. Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol. 2007;137:491–502.
   PubMed Web of Science ®Google Scholar
• Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, . The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells. 2007;25:1737–45.
   PubMed Web of Science ®Google Scholar
• Son BR, Marquez-Curtis LA, Kucia M, Wysoczynski M, Turner AR, Ratajczak J, . Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met Axes and involves matrix metalloproteinases. Stem Cells. 2006;24:1254–64.
   PubMed Web of Science ®Google Scholar
• Schmidt A, Ladage D, Schinkothe T, Klausmann U, Ulrichs C, Klinz FJ, . Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells. 2006;24:1750–8.
   PubMed Web of Science ®Google Scholar
• Schraufstatter IU, Discipio RG, Zhao M, Khaldoyanidi SK. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation. J Immunol. 2009;3827–36.
   PubMedGoogle Scholar
• Gasque P. Complement: a unique innate immune sensor for danger signals. Mol Immunol. 2004;41:1089–98.
   PubMed Web of Science ®Google Scholar
• Lu JH, Teh BK, Wang L, Wang YN, Tan YS, Lai MC, . The classical and regulatory functions of C1q in immunity and autoimmunity. Cell Mol Immunol. 2008; 5:9–21.
   PubMedGoogle Scholar
• Steinberger P, Szekeres A, Wille S, Stöckl J, Selenko N, Prager E, . Identification of human CD93 as the phagocytic C1q receptor (C1qRp) by expression cloning. J Leukoc Biol. 2002;71:133–40.
   PubMedGoogle Scholar
• Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-Weller A. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity. 1997;7:345–55.
   PubMed Web of Science ®Google Scholar
• Dedio J, Jahnen-Dechent W, Bachmann M, Müller-Esterl W. The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein. J Immunol. 1998; 160:3534–42.
   PubMedGoogle Scholar
• Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, . C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001;194:781–95.
   PubMed Web of Science ®Google Scholar
• Jalili A, Marquez-Curtis L, Shirvaikar N, Wysoczynski M, Ratajczak M, Janowska-Wieczorek A. Complement C1q enhances homing-related responses of hematopoietic stem/progenitor cells. Transfusion. 2010;50:2002–10.
   PubMedGoogle Scholar
• Vegh Z, Kew RR, Gruber BL, Ghebrehiwet B. Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR. Mol Immunol. 2006;43:1402–7.
   PubMedGoogle Scholar
• Liu S, Wu J, Zhang T, Qian B, Wu P, Li L, . Complement C1q chemoattracts human dendritic cells and enhances migration of mature dendritic cells to CCL19 via activation of AKT and MAPK pathways. Mol Immunol. 2008; 46:242–9.
   PubMed Web of Science ®Google Scholar
• Ghebrehiwet B, Kew RR, Gruber BL, Marchese MJ, Peerschke EI, Reid KB. Murine mast cells express two types of C1q receptors that are involved in the induction of chemotaxis and chemokinesis. J Immunol. 1995;155:2614–9.
   PubMedGoogle Scholar
• Kuna P, Iyer M, Peerschke EI, Kaplan AP, Reid KB, Ghebrehiwet B. Human C1q induces eosinophil migration. Clin Immunol Immunopathol. 1996;81:48–54.
   PubMedGoogle Scholar
• Leiigh LE, Ghebrehiwet B, Perera TP, Bird IN, Strong P, Kishore U, . C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-protein signalling mechanisms. Biochem J. 1998;330:247–54.
   PubMedGoogle Scholar
• Reca R, Mastellos D, Majka M, Marquez L, Ratajczak J, Franchini S, . Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood. 2003;101:3784–93.
   PubMed Web of Science ®Google Scholar
• Jalili A, Shirvaikar N, Marquez-Curtis L, Qiu Y, Korol C, Lee H, . Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF-1/CXCR4 axis: further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cells. Exp Hematol. 2010; 38:321–32.
   PubMedGoogle Scholar
• Lu C, Li XY, Hu Y, Rowe RG, Weiss SJ. MT1-MMP controls human mesenchymal stem cell trafficking and differentiation. Blood. 2010;115:221–9.
   Google Scholar
• Ryu CH, Park SA, Kim SM, Lim JY, Jeong CH, Jun JA, Oh JH, Park SH, Oh WI, Jeun SS. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways. Biochem Biophys Res Commun. 2010;398:105–10.
   PubMed Web of Science ®Google Scholar
• De Bracco MM, Manni JA. Serum levels of C1q, C1r and C1s in normal and pathologic sera. Arthritis Rheum. 1974;17:121–8.
   PubMedGoogle Scholar
• Li Y, Yu X, Lin S, Li X, Zhang S, Song YH. Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Commun. 2007; 356:780–4.
   PubMed Web of Science ®Google Scholar
• Shirvaikar N, Marquez-Curtis LA, Ratajczak MZ, Janowska-Wieczorek A. Hyaluronic acid and thrombin upregulate MT1-MMP through PI3K and Rac-1 signaling and prime the homing-related responses of cord blood hematopoietic stem/progenitor cells. Stem Cells Dev. 2011;20:19–30.
   Google Scholar
• Li L, Jiang J. Regulatory factors of mesenchymal stem cell migration into injured tissues and their signal transduction mechanisms. Front Med. 2011;5:33–9.
   PubMedGoogle Scholar
• Liu ZJ, Zhuge Y, Velazquez OC. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem. 2009; 106:984–91.
   PubMed Web of Science ®Google Scholar
• Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 2008;15:730–8.
   PubMed Web of Science ®Google Scholar
• Kucia M, Ratajczak J, Reca R, Janowska-Wieczorek A, Ratajczak MZ. Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Blood Cells Mol Dis. 2004; 32:52–7.
   PubMed Web of Science ®Google Scholar
• Ghebrehiwet B, Habicht GS, Beck G. Interaction of C1q with its receptor on cultured cell lines induces an anti-proliferative response. Clin Immunol Immunopathol. 1990;54:148–60.
   PubMedGoogle Scholar
• Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, . C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001;194:781–95.
   PubMed Web of Science ®Google Scholar
• McGreal E, Gasque P. Structure-function studies of the receptors for complement C1q. Biochem Soc Trans. 2002;30:1010–4.
   PubMedGoogle Scholar
• Ghebrehiwet B, Peerschke EI. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. Mol Immunol. 2004;41:173–83.
   PubMed Web of Science ®Google Scholar
• Feng X, Tonnesen MG, Peerschke EIB, Ghebrehiwet B. Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading. J Immunol. 2002; 168:2441–8.
   PubMedGoogle Scholar
• Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34 + hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34 + progenitors to peripheral blood. J Exp Med. 1997;185: 111–20.
   PubMed Web of Science ®Google Scholar
• Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, . Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 199;283:845–8.
   Google Scholar
• Wynn RF, Hart CA, Corradi-Perini C, O'Neill L, Evans CA, Wraith JE, . A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood. 2004;104:2643–5.
   PubMed Web of Science ®Google Scholar
• Wysoczynski M, Reca R, Ratajczak J, Kucia M, Shirvaikar N, Honczarenko M, . Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood. 2005;105:40–8.
   PubMed Web of Science ®Google Scholar
• De Becker A, Van Hummelen P, Bakkus M, Vande Broek I, De Wever J, De Waele M, . Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica. 2007;92:440–9.
   PubMed Web of Science ®Google Scholar
• Tondreau T, Meuleman N, Stamatopoulos B, De Bruyn C, Delforge A, Dejeneffe M, . In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. Cytotherapy. 2009;11:559–69.
   PubMed Web of Science ®Google Scholar
• Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood. 2007; 109:4055–63.
   PubMed Web of Science ®Google Scholar
• Wortzel I, Seger R. The ERK cascade: distinct functions within various subcellular organelles. Genes Cancer. 2011;2:195–209.
   PubMedGoogle Scholar
• Karp JM, Teo GSL. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009;4:206–16.
   PubMed Web of Science ®Google Scholar